Should I Have Adjuvant Immunotherapy? An Interview Study Among Adults with Resected Stage 3 Melanoma and Their Partners.
Ann LivingstoneDonna MilneKathy L FlitcroftDanielle Marie MuscatAlexander M MenziesKirsten HowardMartin R StocklerRachael Lisa MortonPublished in: The patient (2021)
This information can be used by clinicians to support melanoma treatment decision making.